Andrea Charles | 03/13/2013
Every company has compound collections of different sizes, but we all face the same challenge of the rising cost of R&D. - Ludovic Otterbein
Ludovic Otterbein, Head of Global Compound Management and Analytical Chemistry at at H. Lundbeck A/S, speaks to Andrea Charles from Pharma IQ, about the main reasons behind compromised sample integrity, what best practices provide true value in compound management and the biggest bottlenecks the industry is facing. Otterbein...
To continue reading this story Click Here
RECOMMENDED
Upcoming Events
DigIT Pharma AI Commercial Excellence & Health 2025
September 01 - 03, 2025
Palace Hotel Berlin, Germany
Register Now |
View Agenda |
Learn More
AI for Pharma & Healthcare
23 - 25 September, 2025
Amsterdam
Register Now |
View Agenda |
Learn More